Tech Company Financing Transactions
iQure Pharma Funding Round
iQure Pharma closed a $600 thousand Series A financing round on 8/31/2022. Investors included Keiretsu Forum Mid Atlantic, Keiretsu Forum - San Francisco and Keiretsu Forum Northwest.
Transaction Overview
Company Name
Announced On
8/31/2022
Transaction Type
Venture Equity
Amount
$600,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds for research into neuropathic pain compounds.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
251 Little Falls Dr
Wilmington, DE 19808
USA
Wilmington, DE 19808
USA
Phone
Undisclosed
Website
Email Address
Overview
iQure Pharma is a US-based, global biotech company created by entrepreneurs and former Pharma managers focused on the development of new therapeutics for neuropathic pain, an indication with a high unmet medical need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pawel Zolnierczyk
Chief Financial Officer
Anna Rzewuska
Chief Operating Officer
Henk Wilde
Browse more venture capital transactions:
Prev: 8/31/2022: Billogram venture capital transaction
Next: 8/31/2022: Solid Financial Technologies venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs